Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study
- 3 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (3), 393-403
- https://doi.org/10.1093/cid/ciaa666
Abstract
Background: Diagnostic and patients’ management modifications induced by whole-body 18F-FDG-PET/CT had not been evaluated so far in prosthetic valve (PV) or native valve (NV) infective endocarditis (IE)-suspected patients.Methods: In sum, 140 consecutive patients in 8 tertiary care hospitals underwent 18F-FDG-PET/CT. ESC-2015-modified Duke criteria and patients’ management plan were established jointly by 2 experts before 18F-FDG-PET/CT. The same experts reestablished Duke classification and patients’ management plan immediately after qualitative interpretation of 18F-FDG-PET/CT. A 6-month final Duke classification was established.Results: Among the 70 PV and 70 NV patients, 34 and 46 were classified as definite IE before 18F-FDG-PET/CT. Abnormal perivalvular 18F-FDG uptake was recorded in 67.2% PV and 24.3% NV patients respectively (P < .001) and extracardiac uptake in 44.3% PV and 51.4% NV patients. IE classification was modified in 24.3% and 5.7% patients (P = .005) (net reclassification index 20% and 4.3%). Patients’ managements were modified in 21.4% PV and 31.4% NV patients (P = .25). It was mainly due to perivalvular uptake in PV patients and to extra-cardiac uptake in NV patients and consisted in surgery plan modifications in 7 patients, antibiotic plan modifications in 22 patients and both in 5 patients. Altogether, 18F-FDG-PET/CT modified classification and/or care in 40% of the patients (95% confidence interval: 32–48), which was most likely to occur in those with a noncontributing echocardiography (P < .001) or IE classified as possible at baseline (P = .04), while there was no difference between NV and PV.Conclusions: Systematic 18F-FDG-PET/CT did significantly and appropriately impact diagnostic classification and/or IE management in PV and NV-IE suspected patients.Clinical Trials Registration: NCT02287792.Keywords
Funding Information
- French Ministry of Health (13549-P130938)
This publication has 23 references indexed in Scilit:
- Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditisEuropean Heart Journal – Cardiovascular Imaging, 2014
- 18F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Infective EndocarditisThe New England Journal of Medicine, 2013
- Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve EndocarditisJournal of the American College of Cardiology, 2013
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkersStatistics in Medicine, 2010
- 18F-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive BacteremiaJournal of Nuclear Medicine, 2010
- 18F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Health‐Related Quality of Life and Posttraumatic Stress Disorder among Survivors of Left‐Sided Native Valve EndocarditisClinical Infectious Diseases, 2009
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective EndocarditisClinical Infectious Diseases, 2000
- Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990sEuropean Heart Journal, 1996